Ye Xiong
5PUBLICATIONS
53CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 26, 2025
Evaluation and Mitigation of Time-Dependent Confounding Effects in Conventional Exposure-Response Analyses for Oncology Drugs.Xuefen Yin, Ye Xiong, Youwei Bi
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Aug 25, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.Sonia Singh, Diana Bradford, Xiaoxue Li
|Mar 08, 2022
FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation.Sandra J Casak, Shan Pradhan, Lola A Fashoyin-Aje
Pageof 1
Frequent Collaborators
3 joint publications
Richard Pazdur
3 joint publications
Xiaoxue Li
3 joint publications
Claudia P Miller
2 joint publications
Paul G Kluetz
2 joint publications
Sonia Singh
2 joint publications
Diana Bradford
2 joint publications
Jeffrey Kraft
2 joint publications
Rosane Charlab
2 joint publications
Hong Zhao
2 joint publications
Jiang Liu
